TY  - GEN
AU  - Fountzilas,Elena
AU  - Krishnan,Elangovan
AU  - Janku,Filip
AU  - Fu,Siqing
AU  - Karp,Daniel D
AU  - Naing,Aung
AU  - Subbiah,Vivek
AU  - Hong,David S
AU  - Piha-Paul,Sarina A
AU  - Vining,David J
AU  - Tsimberidou,Apostolia-Maria
TI  - A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement
SN  - 1432-0843
PY  - 2019///0826
KW  - Administration, Oral
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Bevacizumab
KW  - Capecitabine
KW  - Female
KW  - Hepatic Artery
KW  - Humans
KW  - Infusions, Intra-Arterial
KW  - Injections, Intravenous
KW  - Liver Neoplasms
KW  - drug therapy
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasm Invasiveness
KW  - Oxaliplatin
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00280-018-3680-y
ER  -